Clinical Outcomes of Chikungunya: A Systematic Literature Review and Meta-analysis
Overview
Tropical Medicine
Authors
Affiliations
Background: Chikungunya is a viral disease caused by a mosquito-borne alphavirus. The acute phase of the disease includes symptoms such as fever and arthralgia and lasts 7-10 days. However, debilitating symptoms can persist for months or years. Despite the substantial impact of this disease, a comprehensive assessment of its clinical picture is currently lacking.
Methods: We conducted a systematic literature review on the clinical manifestations of chikungunya, their prevalence and duration, and related hospitalization. Embase and MEDLINE were searched with no time restrictions. Subsequently, meta-analyses were conducted to quantify pooled estimates on clinical outcomes, the symptomatic rate, the mortality rate, and the hospitalization rate. The pooling of effects was conducted using the inverse-variance weighting methods and generalized linear mixed effects models, with measures of heterogeneity reported.
Results: The systematic literature review identified 316 articles. Out of the 28 outcomes of interest, we were able to conduct 11 meta-analyses. The most prevalent symptoms during the acute phase included arthralgia in 90% of cases (95% CI: 83-94%), and fever in 88% of cases (95% CI: 85-90%). Upon employing broader inclusion criteria, the overall symptomatic rate was 75% (95% CI: 63-84%), the chronicity rate was 44% (95% CI: 31-57%), and the mortality rate was 0.3% (95% CI: 0.1-0.7%). The heterogeneity between subpopulations was more than 92% for most outcomes. We were not able to estimate all predefined outcomes, highlighting the existing data gap.
Conclusion: Chikungunya is an emerging public health concern. Consequently, a thorough understanding of the clinical burden of this disease is necessary. Our study highlighted the substantial clinical burden of chikungunya in the acute phase and a potentially long-lasting chronic phase. Understanding this enables health authorities and healthcare professionals to effectively recognize and address the associated symptoms and raise awareness in society.
Chikungunya virus in Europe: A retrospective epidemiology study from 2007 to 2023.
Liu Q, Shen H, Gu L, Yuan H, Zhu W PLoS Negl Trop Dis. 2025; 19(3):e0012904.
PMID: 40053531 PMC: 11906167. DOI: 10.1371/journal.pntd.0012904.
Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Amaral J, Schoen R, Weinblatt M, Candido E Trop Med Infect Dis. 2025; 10(2).
PMID: 39998058 PMC: 11861052. DOI: 10.3390/tropicalmed10020054.
Lozano-Parra A, Herrera V, Urcuqui-Inchima S, Ramirez R, Villar L Yale J Biol Med. 2024; 97(4):473-489.
PMID: 39703607 PMC: 11650912. DOI: 10.59249/RQYJ3197.
Sloof A, Boer M, Vondeling G, de Roo A, Jaramillo J, Postma M PLoS Negl Trop Dis. 2024; 18(12):e0012713.
PMID: 39652620 PMC: 11658691. DOI: 10.1371/journal.pntd.0012713.
Tortosa F, Gutierrez Castillo G, Izcovich A, Luz K, Dos Santos T, Gonzalez-Escobar G Rev Panam Salud Publica. 2024; 48:e136.
PMID: 39555475 PMC: 11565446. DOI: 10.26633/RPSP.2024.136.